Aurovisc
- Manufacturer
- Aurolab | Aurolab DBA Aurolab Trust
- Effective date
- 2026-01-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- monthly-update
- Hydrated at
- 2026-06-03 17:51:51
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENT
Hypromellose USP 2% w/v
INACTIVE INGREDIENT
- Acetic acid 1%
- Calcium chloride
- Citric acid 0.1465%
- Magnesium Chloride
- Sodium chloride
- Sodium acetate,
- Sodium Citrate
- Potassium chloride
- Purified water.
USE
For use as a lubricant to prevent further irritation or to relieve dryness of the eye
QUESTIONS
Call. 1-800-103-7321,
E-mail : info@aurolab.com
Web :
www.aurolab.com
KEEP OUT OF REACH OF CHILDREN
If swallowed get medical help or contact a Poison Control Center right away.
STOP USE
- Transient blurring of vision
- Ocular discomfort or irritation
- Matting or Stickness of eyelashes
- Photophobia
- Hypersensitivity or edema of the eyelids
DO NOT USE
- If the solution becomes dark brown or any floating particles are observed.
- If you are sensitive to any ingredient in this product
WARNINGS
For External use only
INDIACATIONS AND USAGE
Do not use if package is damaged
Discard after a single use
Do not freeze
Do not resterilize
Purpose
Lubricant
Dose
Instill 1 or 2 drops in the affected eyes as needed
PACKAGE CARTON
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16030-301-02 | Aurovisc | 2 mL in 1 SYRINGE, GLASS | SOLUTION | 2 | 5 |
Products#
Every source-derived product name is available through these pages.
- Aurovisc
- Hypromellose Ophthalmic Solution 2% w/v
- SODIUM ACETATE
- SODIUM CITRATE
- POTASSIUM CHLORIDE
- WATER
- ACETIC ACID
- SODIUM CHLORIDE
- MAGNESIUM CHLORIDE
- CALCIUM CHLORIDE
- CITRIC ACID ACETATE
- HYPROMELLOSE 2208 (15000 MPA.S)
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 16030-301 | 16030-301-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SODIUM ACETATE | 4550K0SC9B | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| WATER | 059QF0KO0R | IACT |
| ACETIC ACID | Q40Q9N063P | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| MAGNESIUM CHLORIDE | 02F3473H9O | IACT |
| CALCIUM CHLORIDE | M4I0D6VV5M | IACT |
| CITRIC ACID ACETATE | DSO12WL7AU | IACT |
| HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | ACTIB |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 4 | 2024-11-27 | full-release | 2026-06-01 00:39:38 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aurovisc | HYPROMELLOSE OPHTHALMIC SOLUTION 2% W/V | Aurolab | e9100312-b105-50a6-e053-2a95a90ac31f | 2026-01-08 | Warnings | 16030-301-02 16030-301 16030030102 47edd91f-7908-3a97-e063-6294a90ad9df e9100312-b105-50a6-e053-2a95a90ac31f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
